FDA label
What is Alvesco used for?
Alvesco contains ciclesonide. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “ALVESCO is indicated for the maintenance treatment of asthma as prophylactic therapy in adult and pediatric patients 12 years of age and older.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Alvesco?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Alvesco, aerosol, metered
Indications and Usage, quoted from the label by Covis Pharma US, Inc (NDA021658). Cross-references to other label sections are left out.
ALVESCO is indicated for the maintenance treatment of asthma as prophylactic therapy in adult and pediatric patients 12 years of age and older.
Limitations of Use:
ALVESCO is not indicated for the relief of acute bronchospasm.
ALVESCO is not indicated for children under 12 years of age.
Source: DailyMed label, set id 9f6112fb-78ef-43cf-8ae3-36370eb45468, version 8, effective February 28, 2025. NDC 70515-711, one of 2 listings for this product.
Questions
What is Alvesco used for?
The FDA label says: “ALVESCO is indicated for the maintenance treatment of asthma as prophylactic therapy in adult and pediatric patients 12 years of age and older.”
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.